Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19)
- Conditions
- COVID-19
- Interventions
- Biological: Reporting of anosmia, ageusia and other clinical symptoms
- Registration Number
- NCT04407494
- Lead Sponsor
- University Hospital, Montpellier
- Brief Summary
Participants are healthcare workers and adult outpatients referred in a COVID-19 screening center. Patients-reported symptoms are collected, then participants underwent a simple olfactory test (CODA for Clinical Olfactory Dysfunction Assessment), prior to swabbing for SARS-CoV-2 diagnosis (RT-PCR). We aimed to evaluate the prevalence of smell and taste disorders, and to calculate the diagnostic value of patient-reported and clinically verified smell disorders in persons with suspected COVID-19.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 809
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description COVID-19 Reporting of anosmia, ageusia and other clinical symptoms Healthcare workers and adult outpatients attending the COVID-19 screening center of the University Hospital of Montpellier, France.
- Primary Outcome Measures
Name Time Method Diagnostic values of anosmia and ageusia for COVID-19 at inclusion Diagnostic values of anosmia and ageusia for COVID-19 with questionnaire
- Secondary Outcome Measures
Name Time Method Diagnostic values of CODA at inclusion Diagnostic values of CODA (Clinical Olfactory dysfunction Assessment) score for COVID-19 : Simple, fast, semi-objective olfactory test developed for epidemic context
Trial Locations
- Locations (1)
Uhmontpellier
🇫🇷Montpellier, France